Pychnogenol is a US registered trademark of the product derived from the pine bark of a tree known as Pinus pinaster. The active ingredients in pycnogenol can be extracted from other sources, including peanut skin, grape seed, and witch hazel bark. It is essentially used for treating circulation problems, allergies, asthma, ringing in the ears, high blood pressure, muscle soreness, pain, diabetes, endometriosis, menopausal symptoms, painful menstrual periods, erectile dysfunction (ED), and retinopathy. Moreover, several manufacturers have focused on developing pycnogenol products that are heat-stable, water soluble and suitable for baked goods & dairy products. Technological advancements in food technology provide lucrative opportunity for the market growth. Pycnogenol extract is standardized to contain 70 ± 5% procyanidins in compliance with USP 28, compounds known for relatively significant antioxidant and anti-inflammatory activity, among other actions. Pycnogenol was ranked among the top 30 selling herbal dietary supplements in the United States in mainstream retail outlets (food, drug, and mass market stores) in 2008 in terms of dollar sales and had a total sales increase of nearly 34% over the previous year.

Request to view Sample Report:

Global market drivers and restraints:-

Although there are many potential uses for Pycnogenol, the most studied use is for improving vascular health as a result of improved endothelial function and venous insufficiency. Controlled clinical trials have been published that demonstrate symptomatic improvement of blood circulation, blood pressure and platelet function normalization, and venous insufficiency. Clinical trials have revealed the ability of pycnogenol to control the symptoms of asthma. Moreover, the pycnogenol market is propelled forward owing to its characteristics such as its potential to reduce menstrual pain, varicose veins, and common cold. Pharmacological studies employing in vitro, animal, and human models have found that Pycnogenol has potent antioxidant activity, anti-inflammatory actions, improves endothelial function (produces vasodilation), reduces platelet aggregation, reduces alpha-glycosidase activity and blood glucose levels, promotes wound healing, alters neurotransmitter levels in children with ADHD, and improves reproductive health by improving sperm morphology and function.

Regional Outlook:-

North America accounted for major market share of Pychnogenol market in light of high use of dietary supplements and SPF in construction activities in the region. Asia Pacific is expected to witness high growth over the forecast period on account of rapid industrialization and growing construction and pharmaceutical sectors in emerging economies such as China and India. European markets are anticipated to witness sluggish growth on account of slow recovery from recession. Emerging economies such as China, India and Brazil are likely to be a more lucrative market owing to the large end-user base along with lower investments in land and labor.

Major Key players:-

Some of the major key who are driving the Pychnogenol market globally are Horphag Research, Arborvitae Health & Wellbeing Pty Ltd, Pure Encapsulations, Maypro Industries, and the like.